Dose-intense cyclophosphamide and etoposide for patients with refractory or high risk non-Hogdkin's lymphoma.
Publication
, Conference
Talbot, JT; Ibom, VK; Barrier, R; Niedzwieki, D; Castro, CM; Moore, JO; Buckley, PJ; Laney, R; Stevenson, D; Brumbaugh, H; Rizzieri, DA; Gockerman, JP
Published in: BLOOD
November 16, 2003
Duke Scholars
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 16, 2003
Volume
102
Issue
11
Start / End Page
287B / 287B
Location
SAN DIEGO, CALIFORNIA
Publisher
AMER SOC HEMATOLOGY
Conference Name
45th Annual Meeting of the American-Society-of-Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Talbot, J. T., Ibom, V. K., Barrier, R., Niedzwieki, D., Castro, C. M., Moore, J. O., … Gockerman, J. P. (2003). Dose-intense cyclophosphamide and etoposide for patients with refractory or high risk non-Hogdkin's lymphoma. In BLOOD (Vol. 102, pp. 287B-287B). SAN DIEGO, CALIFORNIA: AMER SOC HEMATOLOGY.
Talbot, J. T., V. K. Ibom, R. Barrier, D. Niedzwieki, C. M. Castro, J. O. Moore, P. J. Buckley, et al. “Dose-intense cyclophosphamide and etoposide for patients with refractory or high risk non-Hogdkin's lymphoma.” In BLOOD, 102:287B-287B. AMER SOC HEMATOLOGY, 2003.
Talbot JT, Ibom VK, Barrier R, Niedzwieki D, Castro CM, Moore JO, et al. Dose-intense cyclophosphamide and etoposide for patients with refractory or high risk non-Hogdkin's lymphoma. In: BLOOD. AMER SOC HEMATOLOGY; 2003. p. 287B-287B.
Talbot, J. T., et al. “Dose-intense cyclophosphamide and etoposide for patients with refractory or high risk non-Hogdkin's lymphoma.” BLOOD, vol. 102, no. 11, AMER SOC HEMATOLOGY, 2003, pp. 287B-287B.
Talbot JT, Ibom VK, Barrier R, Niedzwieki D, Castro CM, Moore JO, Buckley PJ, Laney R, Stevenson D, Brumbaugh H, Rizzieri DA, Gockerman JP. Dose-intense cyclophosphamide and etoposide for patients with refractory or high risk non-Hogdkin's lymphoma. BLOOD. AMER SOC HEMATOLOGY; 2003. p. 287B-287B.
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 16, 2003
Volume
102
Issue
11
Start / End Page
287B / 287B
Location
SAN DIEGO, CALIFORNIA
Publisher
AMER SOC HEMATOLOGY
Conference Name
45th Annual Meeting of the American-Society-of-Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology